pteridines has been researched along with Local Neoplasm Recurrence in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Grade 4 neutropenia occurred in 37% of patients; common nonhematologic adverse events were fatigue (31%) and nausea (27%)." | 2.75 | The efficacy and safety of BI 2536, a novel Plk-1 inhibitor, in patients with stage IIIB/IV non-small cell lung cancer who had relapsed after, or failed, chemotherapy: results from an open-label, randomized phase II clinical trial. ( Frickhofen, N; Fritsch, H; Gaschler-Markefski, B; Hanft, G; Kortsik, C; Munzert, G; Reck, M; Schuler, M; Sebastian, M; von Pawel, J; Waller, CF, 2010) |
| "In the group of patients with renal cell carcinoma we could not find any correlation between tumor stage and neopterin excretion." | 1.27 | The value of urinary neopterin as an immunological parameter in patients with malignant tumors of the genitourinary tract. ( Aulitzky, W; Frick, J; Fuchs, D; Hausen, A; Joos, H; Reibnegger, G; Wachter, H, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pautier, P | 1 |
| Motte-Rouge, T | 1 |
| Lécuru, F | 1 |
| Classe, JM | 1 |
| Ferron, G | 1 |
| Floquet, A | 1 |
| Kurtz, JE | 1 |
| Freyer, G | 1 |
| Hardy-Bessard, AC | 1 |
| Awad, MM | 1 |
| Chu, QS | 1 |
| Gandhi, L | 1 |
| Stephenson, JJ | 1 |
| Govindan, R | 1 |
| Bradford, DS | 1 |
| Bonomi, PD | 1 |
| Ellison, DM | 1 |
| Eaton, KD | 1 |
| Fritsch, H | 2 |
| Munzert, G | 2 |
| Johnson, BE | 1 |
| Socinski, MA | 1 |
| Sebastian, M | 1 |
| Reck, M | 1 |
| Waller, CF | 1 |
| Kortsik, C | 1 |
| Frickhofen, N | 1 |
| Schuler, M | 1 |
| Gaschler-Markefski, B | 1 |
| Hanft, G | 1 |
| von Pawel, J | 1 |
| Frick, J | 1 |
| Aulitzky, W | 1 |
| Fuchs, D | 1 |
| Hausen, A | 1 |
| Joos, H | 1 |
| Reibnegger, G | 1 |
| Wachter, H | 1 |
1 review available for pteridines and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Prise en charge médicale de la récidive du cancer épithélial de l'ovaire: Medical management of recurrent epithelial ovarian cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Che | 2021 |
2 trials available for pteridines and Local Neoplasm Recurrence
| Article | Year |
|---|---|
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC).
Topics: Administration, Intravenous; Adult; Aged; Cell Cycle Proteins; Disease-Free Survival; Female; Humans | 2017 |
The efficacy and safety of BI 2536, a novel Plk-1 inhibitor, in patients with stage IIIB/IV non-small cell lung cancer who had relapsed after, or failed, chemotherapy: results from an open-label, randomized phase II clinical trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; | 2010 |
1 other study available for pteridines and Local Neoplasm Recurrence
| Article | Year |
|---|---|
The value of urinary neopterin as an immunological parameter in patients with malignant tumors of the genitourinary tract.
Topics: Adolescent; Adult; Aged; Biopterins; Carcinoma, Renal Cell; Chromatography, High Pressure Liquid; Dy | 1985 |